RxAdvocate April, 2024 — Newsletter
FDA Approves New Drug for the Treatment of NASH
FDA Approves First Interchangeable Biosimilars to Prolia and Xgeva
April Recognizes National Infertility Awareness Week
Easter Weekend and Family Time
Stay up-to-date with the latest trends in the healthcare industry via our News, Events and quarterly Newsletters.
FDA Approves New Drug for the Treatment of NASH
FDA Approves First Interchangeable Biosimilars to Prolia and Xgeva
April Recognizes National Infertility Awareness Week
Easter Weekend and Family Time
Wegovy Approved to Decrease Cardiovascular Risk
Oprah’s Recent Take on Weight Loss Medications & What You Should Know
FDA Approves New Gene Therapy
Employee Spotlight
Top 10 Drug Launches 2024
NC Discontinuing Anti-Obesity Drug Coverage
First Ever Frostbite Treatment Approval
Community Involvement
Weight Loss Products: Should Employers Cover?
FDA Approves New Weight Loss Drug, Zepbound
Enter your email address to receive our newsletter.